Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy

被引：0
|
作者：
Jiang, Mengshi [1 ]
Li, Wei [2 ]
Zhu, Chunqi [1 ]
Li, Xiang [1 ]
Zhang, Junlei [1 ]
Luo, Zhenyu [1 ]
Qin, Bing [1 ]
Du, Yongzhong [1 ]
Luo, Lihua [1 ]
You, Jian [1 ]
机构：
[1] College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou,Zhejiang,310058, China
[2] Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas,TX,75390, United States
来源：
Journal of Controlled Release | 2021年 / 329卷
基金：
中国国家自然科学基金;
关键词：
Targeted drug delivery - Hyaluronic acid - Cancer cells - Cytology - Micelles - Diseases - Drug interactions - Tumors - Controlled drug delivery - Covalent bonds - Immune system - Pathology - Sulfur compounds - Drug dosage - Cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1023 / 1036
相关论文
共 50 条
  • [41] Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity
    Abbas, Abdul Baset
    Lin, Bingjing
    Liu, Chen
    Morshed, Arwa
    Hu, Jialiang
    Xu, Hanmei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [42] A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity
    Tao, Huimin
    Cheng, Lu
    Liu, Lihua
    Wang, Hong
    Jiang, Zhijie
    Qiang, Xu
    Xing, Lijun
    Xu, Yifeng
    Cai, Xinying
    Yao, Jing
    Wang, Min
    Qiu, Zheng
    CANCER LETTERS, 2020, 493 : 91 - 101
  • [43] Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV
    Zhang, C.
    Wu, S.
    Xue, X.
    Li, M.
    Qin, X.
    Li, W.
    Han, W.
    Zhang, Y.
    CYTOTHERAPY, 2008, 10 (07) : 711 - 719
  • [44] Exosomes Exercise Inhibition of Anti-Tumor Immunity during Chemotherapy
    LeBleu, Valerie S.
    Kalluri, Raghu
    IMMUNITY, 2019, 50 (03) : 547 - 549
  • [45] Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
    Salehi, Shima
    Ghaderi, Hajarossadat
    Habibi-Anbouhi, Mahdi
    Shoari, Alireza
    Eskafi, Ayda Hassanzadeh
    Sabouri, Alireza
    Hosseininejad-Chafi, Mohammad
    Ardalan, Arghavan Ashja
    Ramezani, Behzad
    Kazemi-Lomedasht, Fatemeh
    Behdani, Mahdi
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
  • [46] FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
    Dahan, Rony
    Sega, Emanuela
    Engelhardt, John
    Selby, Mark
    Korman, Alan J.
    Ravetch, Jeffrey V.
    CANCER CELL, 2015, 28 (03) : 285 - 295
  • [47] Non-specific elimination of tumor- associated neutrophils by antibody-drug conjugates boosts anti-tumor immunity for PD-1 immunotherapy
    Yao, Shili
    Sun, Lu
    Zhu, Xiu
    Xie, Hanfei
    Yang, Tong
    Guo, Peng
    Tang, Huarong
    Zhu, Tao
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Dual inhibition of PD-1 and LAG-3: uncovering mechanisms to reverse T cell exhaustion and enhance anti-tumor immunity
    Zhou, Xiaoxue
    Zhou, Fangfang
    Zhang, Long
    SCIENCE BULLETIN, 2025, 70 (05) : 624 - 626
  • [49] CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity
    Su, Runping
    Gu, Jingjing
    Sun, Juanjuan
    Zang, Jie
    Zhao, Yuge
    Zhang, Tingting
    Chen, Yingna
    Chong, Gaowei
    Yin, Weimin
    Zheng, Xiao
    Liu, Bingbing
    Huang, Li
    Ruan, Shuangrong
    Dong, Haiqing
    Li, Yan
    Li, Yongyong
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [50] Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade
    Christofides, Anthos
    Tijaro-Ovalle, Natalia M.
    Aksoylar, Halil-Ibrahim
    Pal, Rinku
    Mahmoud, Abdelrahman Aa
    Strauss, Laura
    Patsoukis, Nikolaos
    Boussiotis, Vassiliki A.
    BLOOD, 2020, 136
12345